National_Coverage_Determinations_Manual / 220.6.14

Why This Topic Matters

Coverage policy affects whether FDG PET services are payable under Medicare and whether additional study participation or documentation requirements apply. Understanding the scope of the NCD helps organizations align ordering, billing, and compliance workflows with current federal coverage guidance.

Article Sections

1. Staging for Invasive Cervical Cancer as an Adjunct to Conventional Imaging

   Discusses Medicare coverage for FDG PET in a specific cervical cancer staging scenario and the documentation context described in the policy. Also notes related CMS communication channels and a caveat for other staging uses.

2. Brain, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers, and other indications of Cervical Cancer not mentioned in Section A above

   Covers FDG PET indications that fall under coverage with evidence development and the general types of prospective studies referenced by the policy. Includes CMS references for where providers and beneficiaries can find access information.